Reaction
Trichomegaly reporting signals
As of the last recalculation, Trichomegaly appears in 92 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is PANITUMUMAB (PRR 815.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Panitumumab | 35 | 815.3 | 817.1 |
| Erlotinib | 9 | 232.9 | 233.1 |
| Erlotinib Hydrochloride | 11 | 225.7 | 225.9 |
| Cetuximab | 16 | 139.6 | 139.7 |